|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1093 - 0.1255|
|52 Week Range||0.0860 - 0.3260|
|Beta (5Y Monthly)||1.69|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 31, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - June 3, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced the launch of Beacon Medical™ Extra Strength CBD|T Cream, an innovative, premium cannabis topical cream for Canadian medical patients. Wit
VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today released its first quarter 2021 financial and operating results.
VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Ray Laflamme to the board of directors of the Company (the "Board"), effective as of April 12, 2021.